Index of artpub/2021/269681/

Puig Sanz, Lluís
Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial
2021
https://ddd.uab.cat/record/269681